We are live on
!
Find out more
RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$419M
1-Year Est. Return
31.15%
This Fund
S&P 500
This Quarter
Est. Return
+13.76%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$25.4M
(+22%)
Cap. Flow
+$15.3M
Cap. Flow
% of AUM
10.67%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
188
New
30
Increased
86
Reduced
50
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$3.65M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$3.38M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$1.04M |
| 4 |
ARK Innovation ETF
ARKK
|
+$774K |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
+$760K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$856K |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$841K |
| 3 |
iShares S&P 500 Growth ETF
IVW
|
+$821K |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$704K |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$556K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Healthcare | 11.82% |
| 3 | Financials | 10.15% |
| 4 | Communication Services | 8.47% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CME Group
CME
$94.8B
| – | – |
-2,771
| Closed | -$498K |
|
177
iShares US Healthcare Providers ETF
IHF
$1.27B
| – | – |
-8,030
| Closed | -$271K |
|
|
MHF
178
Western Asset Municipal High Income Fund
MHF
$153M
| – | – |
-10,270
| Closed | -$73K |
|
|
179
Novartis
NVS
$298B
| – | – |
-10,849
| Closed | -$856K |
|
|
PHK
180
PIMCO High Income Fund
PHK
$878M
| – | – |
-14,640
| Closed | -$123K |
|
181
Qualcomm
QCOM
$170B
| – | – |
-8,774
| Closed | -$498K |
|
182
Regeneron Pharmaceuticals
REGN
$83.2B
| – | – |
-1,095
| Closed | -$447K |
|
183
Spotify
SPOT
$105B
| – | – |
-1,900
| Closed | -$235K |
|
184
Liberty All-Star Equity Fund
USA
$1.86B
| – | – |
-23,633
| Closed | -$134K |
|
185
Vertex Pharmaceuticals
VRTX
$133B
| – | – |
-2,405
| Closed | -$447K |
|
186
Zoetis
ZTS
$30.9B
| – | – |
-2,632
| Closed | -$226K |
|
|
APU
187
DELISTED
AmeriGas Partners, L.P.
APU
| – | – |
-18,813
| Closed | -$556K |
|
|
BEAT
188
DELISTED
BioTelemetry, Inc.
BEAT
| – | – |
-10,485
| Closed | -$704K |
|
Similar funds
CWAF
MMG
DBRC
CMHI
PIMC
VIS
AI
TI
Roman Butler Fullerton & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Roman Butler Fullerton & Co held 188 positions worth $143M, up 22% from $118M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Roman Butler Fullerton & Co deployed $15.3M of net new capital in Q1 2019, opening 30 new positions and adding to 86 existing holdings. Its largest new stake was Mastercard: 16,986 shares worth $4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $841K trimmed.
- Roman Butler Fullerton & Co's largest Q1 2019 buy was Mastercard: 16,986 shares worth $4M.
- Roman Butler Fullerton & Co added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2019, an estimated $3.38M increase.
- Roman Butler Fullerton & Co's biggest Q1 2019 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $841K.
- Roman Butler Fullerton & Co fully exited Novartis in Q1 2019, selling an estimated $856K.
- Roman Butler Fullerton & Co's ten largest holdings make up 25% of its $143M portfolio in Q1 2019.
- Roman Butler Fullerton & Co opened 30 new positions and closed 15 in Q1 2019.
- Roman Butler Fullerton & Co's portfolio value rose 22% quarter-over-quarter to $143M.
Based on Roman Butler Fullerton & Co's 13F filing for Q1 2019, filed 24 Apr 2019.